A detailed history of Stephens Investment Management Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 530,083 shares of EXAS stock, worth $24.9 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
530,083
Holding current value
$24.9 Million
% of portfolio
0.4%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025

BUY
$40.31 - $58.08 $21.4 Million - $30.8 Million
530,083 New
530,083 $28.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Stephens Investment Management Group LLC Portfolio

Follow Stephens Investment Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Investment Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Investment Management Group LLC with notifications on news.